SEC Form 4 · accession 0001485003-17-000028
Sesen Bio, Inc. · SESN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Hurly
Officer — President and CEO · Director
Period of report
Apr 3, 2017
Accepted (ET)
Apr 5, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001485003
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.28 | Apr 3, 2017 | A | 32,692 | A | — | Apr 2, 2027 | Common Stock | 32,692 | 32,692 | D |
Explanation of responses
- F150% of the shares subject to such option shall vest on grant date, with the remaining 50% of shares underlying the option to vest on the first anniversary of the grant date.